AAP Committee on Drugs.
Wells
J J
JJ
Lamprecht
D E
DE
D000367:Age Factors; D000996:Antitussive Agents / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003915:Dextromethorphan / Q000009:adverse effects / Q000627:therapeutic use; D017408:Guidelines as Topic; D006801:Humans; D007223:Infant; D014663:Nasal Decongestants / Q000627:therapeutic use; D010606:Pharmacy and Therapeutics Committee; D010656:Phenylephrine / Q000009:adverse effects / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012955:Societies, Medical; D014662:Vasoconstrictor Agents / Q000009:adverse effects / Q000627:therapeutic use
D000996:Antitussive Agents; D014663:Nasal Decongestants; D014662:Vasoconstrictor Agents; D010656:Phenylephrine; D003915:Dextromethorphan